Lantern Pharma (LTRN) has priced its IPO of 1.75M common shares at $15.00/share, for gross proceeds of $26.25M.
Underwriters’ over-allotment is an additional 262,500 shares.
Trading kicks off today.
Closing date is June 15.
https://seekingalpha.com/news/3582158-lantern-pharma-prices-ipo-15
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.